E. Atallah and L. Flaherty, Treatment of metastatic malignant melanoma, Curr Treat Options Oncol, vol.6, pp.185-93, 2005.

C. M. Balch, A. C. Buzaid, S. J. Soong, M. B. Atkins, N. Cascinelli et al., Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma, J Clin Oncol, vol.19, pp.3635-3683, 2001.

H. Benlalam, N. Labarrière, B. Linard, L. Derre, E. Diez et al., Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy, Eur J Immunol, vol.31, pp.2007-2022, 2001.

H. Benlalam, V. Vignard, A. Khammari, A. Bonnin, Y. Godet et al., Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients, Cancer Immunol Immunother, vol.56, pp.515-541, 2007.

C. Germeau, W. Ma, F. Schiavetti, C. Lurquin, E. Henry et al., High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens, J Exp Med, vol.201, pp.241-249, 2005.

N. Gervois, N. Labarrière, L. Guiner, S. Pandolfino, M. C. Fonteneau et al., High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells, Clin Cancer Res, vol.6, pp.1459-67, 2000.
URL : https://hal.archives-ouvertes.fr/inserm-02482162

J. Huang, H. T. Khong, M. E. Dudley, M. El-gamil, Y. F. Li et al., Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression, J Immunother, vol.28, pp.258-67, 2005.

N. N. Hunder, H. Wallen, J. Cao, D. W. Hendricks, J. Z. Reilly et al., Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1, N Engl J Med, vol.358, pp.2698-703, 2008.

T. Jung, U. Schauer, C. Heusser, C. Neumann, and C. Rieger, Detection of intracellular cytokines by flow cytometry, J Immunol Methods, vol.159, pp.197-207, 1993.

A. Khammari, J. M. Nguyen, M. C. Pandolfino, G. Quereux, A. Brocard et al., Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma, Cancer Immunol Immunother, vol.56, pp.1853-60, 2007.

N. Labarrière, B. Dreno, and F. Jotereau, Lymphocyte biomarkers of clinical responses to adoptive immunotherapy of malignant melanoma, Cur Cancer Ther Rev, vol.4, pp.125-134, 2008.

N. Labarrière, M. C. Pandolfino, N. Gervois, A. Khammari, M. H. Tessier et al., Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients, Cancer Immunol Immunother, vol.51, pp.532-540, 2002.

N. Labarrière, M. C. Pandolfino, D. Raingeard, L. Guiner, S. Diez et al., Frequency and relative fraction of tumor antigen-specific T cells among lymphocytes from melanoma-invaded lymph nodes, Int J Cancer, vol.78, pp.209-224, 1998.

A. Mackensen, N. Meidenbauer, S. Vogl, M. Laumer, J. Berger et al., Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma, J Clin Oncol, vol.24, pp.5060-5069, 2006.

N. Meidenbauer, J. Marienhagen, M. Laumer, S. Vogl, J. Heymann et al., Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients, J Immunol, vol.170, pp.2161-2170, 2003.

S. Sarkar, V. Kalia, W. N. Haining, B. T. Konieczny, S. Subramaniam et al., Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates, J Exp Med, vol.205, pp.625-665, 2008.

D. Valmori, J. F. Fonteneau, C. M. Lizana, N. Gervois, D. Lienard et al., Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues, J Immunol, vol.160, pp.1750-1758, 1998.

V. Vignard, B. Lemercier, A. Lim, M. C. Pandolfino, Y. Guilloux et al., Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells, J Immunol, vol.175, pp.4797-805, 2005.

C. Yee, J. A. Thompson, D. Byrd, S. R. Riddell, P. Roche et al., , 2002.

, Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells, Proc Natl Acad Sci, vol.99, pp.16168-73

C. Yee, J. A. Thompson, P. Roche, D. R. Byrd, P. P. Lee et al., Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo, J Exp Med, vol.192, pp.1637-1681, 2000.

J. Zhou, X. Shen, J. Huang, R. J. Hodes, S. A. Rosenberg et al., Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy, J Immunol, vol.175, pp.7046-52, 2005.